I'm on 10mg of Mounjaro but there's one side effect nobody talks about that's so bad I might even come off
PUT OFF I'm on 10mg of Mounjaro but there's one side effect nobody talks about that's so bad I might even come off
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
A WOMAN has shared the grim side effect from Mounjaro that's so bad she's thinking of stopping the drug altogether.
Kelly, from the UK, took to social media to share how her journey on the weight loss jab was going.
Sign up for Scottish Sun
newsletter
Sign up
2
Kelly is on Mounjaro but hs found it's stopped working
Credit: TikTok/keprazy
2
Now she's constantly hungry but unable to eat
Credit: TikTok/keprazy
Kelly is currently on 10mg of Mounjaro a week, but she said it wasn't working as it was supposed to.
She said the drug had stopped suppressing her appetite but that all food now tasted horrible so she was struggling to eat.
Sharing a clip of what she consumed in a day, Kelly started with a peppermint tea.
She revealed she needed it to help soothe the side effects of having a takeaway the night before while on Mounjaro.
She then had a small portion of spaghetti bolognese she had made which was the only thing she managed to eat that day.
After her lunch, Kelly had a snack which consisted of sushi and a pepperami snack box and an iced coffee.
But as soon as the food touched her lips she grimaced and couldn't stand the taste of it.
After her failed lunch, Kelly tried to eat a protein bar and strawberries but was again put off by the taste.
"This was also disgusting and I was just over it all," she penned.
When she went home, Kelly made a bowl of cheesy pasta, but as soon as she made it, she couldn't bring herself to eat it.
I've lost nearly 6 stone in 9 months on fat jabs - trolls call me 'lazy' & say it's the 'easy way out' but I don't care
She left over half, adding that she should have just 'ordered a pizza'.
"I feel like this is the side of Mounjaro people don't see!" she captioned the post.
"I'm starving but don't fancy anything!! It is such a struggle! I might actually come off Mounjaro at this point!"
She went on to explain that the drug hadn't suppressed her appetite but had made her taste buds change.
She added: "I don't think people understand my situation, I don't have suppression, I'm not not eating food because of my dose, the Mounjaro has changed my taste buds.
"I AM HUNGRY and I am able to eat how I used to - I just have different tastes now but I can't stomach anything."
The clip has gone viral on her TikTok account @keprazy with over 214k views and 2,400 likes.
People were quick to share their own experiences in the comments.
What are the other side effects of weight loss jabs?
Like any medication, weight loss jabs can have side effects.
Common side effects of injections such as Ozempic include:
Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts.
Vomiting: Can occur, often in conjunction with nausea.
Diarrhea: Some people experience gastrointestinal upset.
Constipation: Some individuals may also experience constipation.
Stomach pain or discomfort: Some people may experience abdominal pain or discomfort.
Reduced appetite: This is often a desired effect for people using Ozempic for weight loss.
Indigestion: Can cause a feeling of bloating or discomfort after eating.
Serious side effects can also include:
Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting.
Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon.
Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic.
Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic.
Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
One person wrote: "I came off weight loss injections after having lost 3st on them and lost a further 4st... My appetite was forever changed."
Another commented: "I can't eat eggs, dairy, meat and fried foods now!"
"Omg this!! I do have the suppression, but even when I feel hungry I can't like any food," penned a third.
Meanwhile a fourth said: "Everything tastes so ordinary now."
"Yes Mounjaro has definitely changed what foods I used to like,' claimed a fifth
Someone else added: "I was the same! Could eat takeaway all day long but couldn't eat anything normal."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
18 minutes ago
- Reuters
Demand for obesity drugs shoots up in India as Lilly, Novo jostle for market share
HYDERABAD, July 7 (Reuters) - Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly (LLY.N), opens new tab and Novo Nordisk ( opens new tab are competing for market share, data from research firm Pharmarack showed on Monday. Sales of Lilly's Mounjaro, which launched in late March, doubled from May to June, reaching 87,986 units or 260 million rupees ($3.03 million), Pharmarack said in a virtual session. Between March and May, Lilly sold a total of 81,570 Mounjaro units in India. Meanwhile, Novo sold 1,788 units of Wegovy in India since its late-June launch, Pharmarack said. Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst three globally for high obesity rates, according to a study published in the medical journal the Lancet. The Indian obesity market has grown fivefold since 2021 and is valued at 6.28 billion rupees, according to the research firm. Affordability and willingness to try new drugs for obesity have propelled the growth of the market, Pharmarack's Vice President (Commercial) Sheetal Sapale said. Wegovy's active ingredient, semaglutide, dominates the market with a two-thirds share in India while Mounjaro's active ingredient, Tirzepatide, has captured 8% of the market, Pharmarack said. As of June, the semaglutide market in India was valued at 4.12 billion rupees, and Tirzepatide at 500 million rupees, the research firm said. Novo has sold oral versions of semaglutide for diabetes in India since 2022. Semaglutide will lose patent protection in India in 2026, and generic drugmakers are aiming to produce cheaper versions of Wegovy as India becomes a key battleground for drugmakers seeking to grab a share of the global obesity market. Novo and Lilly's drugs help control blood sugar and slow digestion, making users feel fuller for longer. ($1 = 85.9200 Indian rupees)
Scottish Sun
an hour ago
- Scottish Sun
‘King Kong' of fat jabs ‘help you TONE up' – as scientists discover surprising ‘fitness boost'
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection - known as the 'King Kong' of weight loss jabs - may swerve this side effect. Sign up for Scottish Sun newsletter Sign up 2 The weight loss jab Mounjaro leads to no more muscle loss than you'd get from losing weight without the medication Credit: Getty 2 Scientists also found that jab may help remove fat from within muscles, boosting exercise performance Credit: Getty In fact, it could help users tone up, researchers from the University of Glasgow said. Their study analysed the body composition of more than 200 people and found they lost no more muscle from the weight loss jab Mounjaro than if they had lost weight a different way. It suggested muscle loss from shedding weight will be similar with or without the injections. But researchers also noticed that Mounjaro-users also lost fat from inside their muscles - much more than they would have done from losing weight without the medicines. Getting rid of the fat marbling muscles may improve how they work and boost people's ability to exercise, scientists said. That's because the fat that gets into muscles and surrounds vital organs - which is different from the fat layer just beneath the skin - has been linked with muscle weakness and poorer physical performance. The study's lead author Naveed Sattar, a professor of metabolic medicine at Glasgow University's Institute of Cardiovascular and Medical Sciences, told The Times: 'For the majority of people using the weight-loss injection tirzepatide [the active ingredient in Mounjaro], they experience an increase in their capacity for activity, meaning they can often walk for longer or be more active than before. 'Having less muscle fat usually means the remaining fat muscle cells are more efficient in generating power, which could explain the boost to people's exercise abilities. "These results are hugely encouraging as less muscle fat is also linked to a reduced risk of cardiovascular disease and type 2 diabetes in many studies. 'However, we don't yet know how weight-loss injections remove additional muscle fat, and more evidence is needed to understand the mechanisms involved.' When someone is overweight or not very active, they're more likely to get streaks of fat in their muscles. It's possible to reduce it by doing aerobic exercise such as jogging, walking and cycling. But for people have difficulty exercising due to their weight or other conditions, using weight loss jabs to get rid of muscle fat holds promise. The study, published in The Lancet Diabetes & Endocrinology, was conducted at 45 medical research centres and hospitals in eight countries - including Greece, Hungary, Italy, Romania, Spain and the US. It assessed 246 people with type 2 diabetes who were either given varying doses of Mounjaro - 5 mg, 10 mg, or 15 mg - once a week, or daily insulin injections. Researchers used MRI scans to measure amount of muscle and fat each person had in their thighs before the treatment, and a year after starting it. They compared muscle loss in tirzepatide users to typical muscle loss in people of the same age and sex, who lost the same amount of weight without the jabs - using the data of 3,000 people from the UK Biobank study. Both groups lost a similar amount of muscle. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. But Mounjaro-takers lost 0.5 per cent more fat from within their muscles. Researchers didn't assess participants' ability to exercise after taking the jabs. "As the study was not specifically designed to evaluate muscle-related changes, assessments of strength, mobility, and physical performance are not available," they wrote. They also said other factors may have lead to loss of fat within muscles. "There were no specific instructions in our study about dietary changes or exercise training beyond the standard of care at each site and region, and we cannot exclude the influence that individual differences in lifestyle management might have had on the results," scientists wrote. "It has been reported that resistance exercise training or dietary supplements might exert a positive effect on muscle composition, and are recommended when substantial weight reduction is achieved or expected (eg. after bariatric surgery)." The findings indicate that Mounjaro gets rid of fat from different parts of the body better than conventional weight loss, scientists said, as well as dimming hunger pangs. That could help to explain evidence suggesting weight-loss injections may reduce the risk of diabetes and many other chronic diseases. Researchers called for more studies "into long-term changes in muscle strength, mobility, and physical performance in people treated with tirzepatide".
The Sun
an hour ago
- The Sun
‘King Kong' of fat jabs ‘help you TONE up' – as scientists discover surprising ‘fitness boost'
ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection - known as the 'King Kong' of weight loss jabs - may swerve this side effect. 2 In fact, it could help users tone up, researchers from the University of Glasgow said. Their study analysed the body composition of more than 200 people and found they lost no more muscle from the weight loss jab Mounjaro than if they had lost weight a different way. It suggested muscle loss from shedding weight will be similar with or without the injections. But researchers also noticed that Mounjaro-users also lost fat from inside their muscles - much more than they would have done from losing weight without the medicines. Getting rid of the fat marbling muscles may improve how they work and boost people's ability to exercise, scientists said. That's because the fat that gets into muscles and surrounds vital organs - which is different from the fat layer just beneath the skin - has been linked with muscle weakness and poorer physical performance. The study's lead author Naveed Sattar, a professor of metabolic medicine at Glasgow University's Institute of Cardiovascular and Medical Sciences, told The Times: 'For the majority of people using the weight-loss injection tirzepatide [the active ingredient in Mounjaro], they experience an increase in their capacity for activity, meaning they can often walk for longer or be more active than before. 'Having less muscle fat usually means the remaining fat muscle cells are more efficient in generating power, which could explain the boost to people's exercise abilities. "These results are hugely encouraging as less muscle fat is also linked to a reduced risk of cardiovascular disease and type 2 diabetes in many studies. 'However, we don't yet know how weight-loss injections remove additional muscle fat, and more evidence is needed to understand the mechanisms involved.' When someone is overweight or not very active, they're more likely to get streaks of fat in their muscles. It's possible to reduce it by doing aerobic exercise such as jogging, walking and cycling. But for people have difficulty exercising due to their weight or other conditions, using weight loss jabs to get rid of muscle fat holds promise. The study, published in The Lancet Diabetes & Endocrinology, was conducted at 45 medical research centres and hospitals in eight countries - including Greece, Hungary, Italy, Romania, Spain and the US. It assessed 246 people with type 2 diabetes who were either given varying doses of Mounjaro - 5 mg, 10 mg, or 15 mg - once a week, or daily insulin injections. Researchers used MRI scans to measure amount of muscle and fat each person had in their thighs before the treatment, and a year after starting it. They compared muscle loss in tirzepatide users to typical muscle loss in people of the same age and sex, who lost the same amount of weight without the jabs - using the data of 3,000 people from the UK Biobank study. Both groups lost a similar amount of muscle. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. But Mounjaro-takers lost 0.5 per cent more fat from within their muscles. Researchers didn't assess participants' ability to exercise after taking the jabs. "As the study was not specifically designed to evaluate muscle-related changes, assessments of strength, mobility, and physical performance are not available," they wrote. They also said other factors may have lead to loss of fat within muscles. "There were no specific instructions in our study about dietary changes or exercise training beyond the standard of care at each site and region, and we cannot exclude the influence that individual differences in lifestyle management might have had on the results," scientists wrote. "It has been reported that resistance exercise training or dietary supplements might exert a positive effect on muscle composition, and are recommended when substantial weight reduction is achieved or expected (eg. after bariatric surgery)." The findings indicate that Mounjaro gets rid of fat from different parts of the body better than conventional weight loss, scientists said, as well as dimming hunger pangs. That could help to explain evidence suggesting weight-loss injections may reduce the risk of diabetes and many other chronic diseases.
